Mark Barrett is the Group CEO & Co-Founder at APC Ltd and VLE Therapeutics. He also serves as an Adjunct Professor at University College Dublin. With a background in Chemical Engineering and a PhD in Optimization and Scale-Up, Mark has extensive experience in research and development within the pharmaceutical industry. His current focus is on accelerating medicines development and reimagining CGT and vaccine manufacture through breakthroughs in manufacturing science and digitization. Mark has also worked at Solid State Pharmaceutical Cluster Ireland, Schering-Plough, and has experience as a Research Intern at FSA/NASA.
September, 2020 - present